PHP
UTHR icon

Parkman Healthcare Partners’s United Therapeutics UTHR Stock Holding History

Parkman Healthcare Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,000
Closed -$9.22M – 110
2025
Q3 		$9.22M Buy
22,000
+13,189
+150% +$4.44M 0.96% 37
2025
Q2 		$2.53M Sell
8,811
-1,421
-14% -$425K 0.29% 77
2025
Q1 		$3.15M Sell
10,232
-27,240
-73% -$9.34M 0.37% 63
2024
Q4 		$13.2M Sell
37,472
-26,559
-41% -$9.76M 1.76% 19
2024
Q3 		$22.9M Sell
64,031
-47,350
-43% -$16M 2.93% 7
2024
Q2 		$35.5M Sell
111,381
-16,818
-13% -$4.45M 4.75% 3
2024
Q1 		$29.4M Sell
128,199
-33,340
-21% -$7.52M 3.61% 2
2023
Q4 		$35.5M Buy
161,539
+23,211
+17% +$5.35M 5% 2
2023
Q3 		$31.2M Buy
138,328
+15,350
+12% +$3.54M 5.72% 2
2023
Q2 		$27.1M Buy
122,978
+14,906
+14% +$3.3M 4.71% 1
2023
Q1 		$24.2M Buy
108,072
+7,370
+7% +$1.82M 5.26% 1
2022
Q4 		$28M Buy
100,702
+18,432
+22% +$4.65M 7.46% 1
2022
Q3 		$17.2M Sell
82,270
-9,536
-10% -$2.13M 4.9% 1
2022
Q2 		$21.6M Buy
91,806
+17,699
+24% +$3.6M 7.97% 1
2022
Q1 		$13.3M Sell
74,107
-16,091
-18% -$3.07M 3.89% 2
2021
Q4 		$19.5M Sell
90,198
-4,126
-4% -$810K 4.3% 2
2021
Q3 		$17.4M Hold
94,324
– – 4.4% 4
2021
Q2 		$16.9M Buy
94,324
+19,450
+26% +$3.7M 3.7% 5
2021
Q1 		$12.5M Buy
+74,874
New +$12.5M 2.91% 10

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Parkman Healthcare Partners's UTHR Position: Q4 2025 in Review

Parkman Healthcare Partners sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 22,000 shares — an estimated $9.22M sold.

Parkman Healthcare Partners first reported a position in UTHR in Q1 2021 and held it in 19 quarters. The position peaked at $35.5M in Q4 2023. 837 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • Parkman Healthcare Partners reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 22,000 United Therapeutics shares in Q4 2025, an estimated $9.22M.
  • Parkman Healthcare Partners first reported a position in United Therapeutics in Q1 2021 and held it in 19 quarters.
  • Parkman Healthcare Partners's United Therapeutics position peaked at $35.5M in Q4 2023.
  • 837 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on Parkman Healthcare Partners's 13F filing for Q4 2025, filed 17 Feb 2026.